Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2024 08:00 ET | Source: Recursion Pharmaceuticals

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

SALT LAKE CITY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Chris...
December 20, 2023 07:59 ET | Source: Recursion Pharmaceuticals

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today...
November 09, 2023 09:41 ET | Source: Recursion Pharmaceuticals

Bayer and Recursion Focus Research Collaboration on Oncology

Berlin, Germany and Salt Lake City, USA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug...
November 09, 2023 07:58 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

Entered into a collaboration with Tempus giving Recursion access to over 20 petabytes of multimodal oncology data for the purpose of training causal AI models together with Recursion’s proprietary...
November 02, 2023 08:05 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conference

SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
September 05, 2023 16:30 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
September 05, 2023 07:59 ET | Source: Recursion Pharmaceuticals

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has...
August 08, 2023 08:00 ET | Source: Recursion Pharmaceuticals

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has...
August 08, 2023 07:58 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein interactions for approximately 36 billion compounds in the Enamine REAL Space, reported to be the world’s...
August 01, 2023 08:30 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conference

SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...